The University of Chicago Header Logo

Connection

Olufunmilayo Olopade to Raloxifene Hydrochloride

This is a "connection" page, showing publications Olufunmilayo Olopade has written about Raloxifene Hydrochloride.
  1. Tamoxifen and the risk of breast cancer in women with a BRCA1 or BRCA2 mutation. Breast Cancer Res Treat. 2023 Sep; 201(2):257-264.
    View in: PubMed
    Score: 0.059
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.